B38.81 Prostatic coccidioidomycosis

Name of the Condition

• Prostatic coccidioidomycosis

Summary

Prostatic coccidioidomycosis is a fungal infection of the prostate gland caused by Coccidioides species. It is a form of extrapulmonary coccidioidomycosis, where the infection spreads from the lungs to the prostate. The condition may present with urinary symptoms or be asymptomatic, and its severity depends on the host’s immune status.

Causes

The infection originates from inhaling airborne spores of Coccidioides fungi, which are endemic to arid regions like the southwestern United States, Mexico, and parts of Central and South America. After initial pulmonary infection, the fungi can disseminate to the prostate, particularly in individuals with weakened immune systems.

Risk Factors

• Residence or travel to endemic regions, especially during dry, dusty seasons.
• Immunocompromised states, including HIV/AIDS, organ transplantation, or prolonged corticosteroid use.
• Advanced age.
• Prostate conditions that may facilitate fungal spread (e.g., benign prostatic hyperplasia).

Symptoms

• Urinary frequency, urgency, or hesitancy.
• Dysuria (painful urination).
• Pelvic or perineal discomfort.
• Asymptomatic cases may occur, especially in early stages.

Diagnosis

Diagnosis involves clinical evaluation, imaging (e.g., transrectal ultrasound or MRI of the prostate), and laboratory testing. Urine or prostate tissue cultures, histopathology, or antigen/antibody tests may confirm Coccidioides infection. A history of exposure to endemic areas supports the diagnosis.

Treatment Options

Treatment typically includes antifungal medications, such as fluconazole or itraconazole, for several months. Severe or refractory cases may require amphotericin B. Management of underlying immunocompromising conditions is also important.

Prognosis and Follow-Up

Prognosis is generally favorable with appropriate antifungal therapy, especially in immunocompetent individuals. Follow-up includes monitoring symptoms, repeat imaging, and laboratory tests to ensure resolution. Immunocompromised patients may need prolonged treatment and closer surveillance.

Complications

• Chronic prostatitis or recurrent infection.
• Urinary obstruction or retention.
• Dissemination to other organs (e.g., bones, skin) in severe cases.

Lifestyle & Prevention

• Avoid exposure to dust in endemic regions (e.g., wear masks during construction or farming).
• Maintain good immune health (e.g., manage chronic conditions, avoid unnecessary immunosuppression).
• Seek prompt medical care for respiratory symptoms after travel to endemic areas.

When to Seek Professional Help

Consult a healthcare provider if you experience persistent urinary symptoms (e.g., pain, frequency) or have a history of exposure to Coccidioides and develop new or worsening symptoms. Immunocompromised individuals should seek care promptly for any concerning signs.

Tips for Medical Coders

Document the site of infection (prostate) and any associated symptoms or complications. Ensure the diagnosis is supported by clinical findings, imaging, or laboratory results. Code B38.81 is specific to prostatic involvement; do not use this code for pulmonary or other extrapulmonary sites without clear documentation.